SJÖGREN'S SYNDROME
Clinical trials for SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sjögren's drug safety checked in long-term extension trial
Disease control Recruiting nowThis study looks at the long-term safety of a drug called dazodalibep for people with Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. About 844 adults who already completed a prior phase 3 study will receive the drug for up to 48 more weeks. Researchers …
Matched conditions: SJÖGREN'S SYNDROME
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 26, 2026 07:15 UTC
-
Last-resort drug access program opens for rare immune disorders
Disease control AVAILABLEThis program provides access to the experimental drug VAY736 (ianalumab) for patients with serious or life-threatening immune conditions like primary immune thrombocytopenia or Sjögren's syndrome. It is only available when no other treatments work and the patient cannot join a cl…
Matched conditions: SJÖGREN'S SYNDROME
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New eye drops aim to soothe Sjögren's dry eye
Symptom relief Recruiting nowThis study tests whether a special protein eye drop (rhPRG4) can safely relieve dry eye symptoms in people with Sjögren's syndrome. About 80 adults in Australia will receive either the active drops or a placebo for 28 days. The goal is to see if the drops improve the surface of t…
Matched conditions: SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated May 26, 2026 07:11 UTC